The substantial beat on both earnings per share and sales estimates, coupled with the impressive year-over-year growth, is likely to generate positive investor sentiment and could lead to a short-term increase in Fennec Pharmaceuticals' stock price. The magnitude of the beat and growth rates are significant indicators of the company's performance and potential future growth, making this news highly relevant and important for investors.